Apple (AAPL)

Apple is reportedly grappling with the slow uptake of its Vision Pro headset, attributed to its high price tag and lack of compelling features.

Each of these companies has robust long-term opportunities.

Peter Lynch has underscored the importance of long-term investment strategies, advising against the pursuit of quick returns.

Berkshire Hathaway recently filed its second-quarter 13F form, revealing its stock holdings at the end of June.

This ETF has outperformed the S&P 500 handily over various multi-year periods.

Apple unintentionally revealed information about its future products, with the details discovered in the company's publicly available software code.

Consumer Tech News (Aug 11–15): Earnings season winds down as sentiment slips, China stimulus lifts markets, and Cisco & Applied Materials shine amid volatile macro conditions.

This Vanguard exchange-traded fund can help investors beat the S&P 500, but it comes with risks.

Apple is looking to change the narrative that it's no longer a technology innovator.

Nvidia can sell its AI chips in China, and hyperscalers are spending more heavily on data center infrastructure than Wall Street anticipated.

Cybersecurity platform provider Palo Alto Networks (NASDAQ:PANW) will be announcing earnings results this Monday after market hours. Here’s what investors should know.

Apple stock hasn't moved this year, but it isn't the first time the market has soured on it.

Is Meta's Reality Labs segment looking to make iPhones obsolete? Its AI glasses business may be gunning for the $400 billion smartphone market.

BMNR’s bold plan to own 5% of Ethereum could reshape the crypto market. Discover the institutional shift fueling ETH’s next bull run.

The Vanguard Dividend Appreciation ETF has an excellent balance of growth, income, and value stocks.

Apple is closing in on $3.5 trillion in market cap, but it could take time to reach $4 trillion.

The company is adding a new $100 billion investment in the United States.

These companies are playing a leading role in powering the S&P 500 to record highs.

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.2% in the afternoon session after the stock extended its positive momentum partly fueled by reports of major insider buying by top executives, including the CEO, which is often seen as a strong vote of confidence. Additionally, news that the company has signed a multi-billion dollar deal with an AI health tech company (Superluminal) to discover and develop new obesity medicines also contributed to the positive sentiment. Finally, the company's decision to increase the price of its popular diabetes and weight-loss drug Mounjaro in the UK, in response to US political pressure, was also seen as a positive for future revenue.

David Tepper sold casino stocks and bought airline stocks in the second quarter. Here's a look at the changes made to the Appaloosa hedge fund.

The Oracle of Omaha is driving UnitedHealth stock higher.